CIK 0000885725 · Large accelerated filer
BOSTON SCIENTIFIC CORP
Sign in to watch- Ticker
- BSX
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 042695240
- Phone
- 508-683-4000
- Business address
- 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA, 01752-1234
- Open-market buys, last 90 days
- $100,408
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$100,408. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-01 | Sorenson John Bradley EVP, Global Operations | Option exercise 10b5-1 | +4,469 | 41,565 | ||
| 2025-01-01 | Sorenson John Bradley EVP, Global Operations | Shares withheld for taxes 10b5-1 | −2,127 | $89.32 | $190K | 39,438 |
| 2025-01-01 | Sorenson John Bradley EVP, Global Operations | Option exercise · Performance Share Units 10b5-1 | −4,469 | 0 | ||
| 2025-01-01 | Mirviss Jeffrey B. EVP&Pres, Periph Intervent | Option exercise 10b5-1 | +10,430 | 38,884 | ||
| 2025-01-01 | Mirviss Jeffrey B. EVP&Pres, Periph Intervent | Shares withheld for taxes 10b5-1 | −3,278 | $89.32 | $293K | 35,606 |
| 2025-01-01 | Mirviss Jeffrey B. EVP&Pres, Periph Intervent | Option exercise · Performance Share Units 10b5-1 | −10,430 | 0 | ||
| 2025-01-01 | Mahoney Michael F Chairman, President & CEO | Option exercise | +57,121 | 1,578,326 | ||
| 2025-01-01 | Mahoney Michael F Chairman, President & CEO | Shares withheld for taxes | −25,656 | $89.32 | $2.3M | 1,552,670 |
| 2025-01-01 | Mahoney Michael F Chairman, President & CEO | Option exercise · Performance Share Units | −57,121 | 0 | ||
| 2025-01-01 | Fitzgerald Joseph Michael EVP & Group Pres, Cardiology | Option exercise | +13,907 | 162,025 | ||
| 2025-01-01 | Fitzgerald Joseph Michael EVP & Group Pres, Cardiology | Shares withheld for taxes | −6,425 | $89.32 | $574K | 155,600 |
| 2025-01-01 | Fitzgerald Joseph Michael EVP & Group Pres, Cardiology | Option exercise · Performance Share Units | −13,907 | 0 | ||
| 2025-01-01 | Butcher Arthur C EVP& Grp Pres, MedSurg & APAC | Option exercise | +8,940 | 9,918 | ||
| 2025-01-01 | Butcher Arthur C EVP& Grp Pres, MedSurg & APAC | Shares withheld for taxes | −4,416 | $89.32 | $394K | 5,502 |
| 2025-01-01 | Butcher Arthur C EVP& Grp Pres, MedSurg & APAC | Option exercise · Performance Share Units | −8,940 | 0 | ||
| 2025-01-01 | Brown Vance R SVP, GC and Corp. Secretary | Option exercise | +6,456 | 40,866 | ||
| 2025-01-01 | Brown Vance R SVP, GC and Corp. Secretary | Shares withheld for taxes | −1,991 | $89.32 | $178K | 38,875 |
| 2025-01-01 | Brown Vance R SVP, GC and Corp. Secretary | Option exercise · Performance Share Units | −6,456 | 0 | ||
| 2025-01-01 | Brennan Daniel J. EVP and CFO | Option exercise 10b5-1 | +14,901 | 238,822 | ||
| 2025-01-01 | Brennan Daniel J. EVP and CFO | Shares withheld for taxes 10b5-1 | −5,212 | $89.32 | $466K | 233,610 |
Page 26 of 40 · 791 trades